(duct lavage) (duct brushing)

, Msc Montpellier 1, - & . . . Montpellier-Nimes MANOSMED: ,

1

2

-

.: 0.2 3.8 %: 1/ 3000 .

>3% 23 47 ( : 33 ).

, .

Pavlidis N , Pentheroudakis G. Cancer Treat Rev. 2005;31:439-47.Ring AE, et al, Ann Oncol. 2005;16:1855-60 Mignot L., 2002;

3

: Ca ;

IUGR : ;

Ca ;

;

The short term & long term effect on breast cancer risk: a prospective study of 802.457 parous Norwegian women, Albrektsen G. et als, Br.J. Cancer 1995,72.

4

: , , .

: .

: .

6

7

MRI : Gadolinium

FNA

Core biopsy

. 63-78%. : 25%. - < 50 mrads. , ,

8

3D

9

10

Shellock FG, Crues JV. MR procedures: biologic effects, safety, and patient care. Radiology 2004; 232:635.

MRI

11

FNA & CYTOLOGY: + -

12

:

13

: NAI

14

:75-90%: (Grade 3), .` : 4-5 %. & . HER2 16-58%.

Middleton LP et al, Cancer. 2003;98:1055-60. Bonnier P et al, Int J Cancer. 1997;72:720-7.Ring AE et al, J Clin Oncol. 2005;23:4192-7. Elledge RM et al, Cancer. 1993;71:2499-506.

15

: -: , CT : ,

(CT) - : .

(MRI): +- NAI

:

Bone scanning in pregnant patients with breast carcinoma.Baker J, Ali A, Groch MW, Fordham E, Economou SGClin Nucl Med. 1987;12:519.

16

, : .

The daily increased risk for developing axillary metastasis for an untreated breast carcinoma in pregnant women is 0.057% (1,8% per month !!)Nettleton J et al, Obstet Gynecol. 1996;87:414-8.

: NAI.

: NAI.

& : , .

.

17

. .

Loibl et al, Cancer 2006; Kuerer et al, Surgery 2002Annane K, Bellocq JP, Brettes JP, Mathelin C. Infiltrative breast cancer during pregnancy and conservative surgery. Fetal Diagn Ther 2005; 20:442

18

.

1 , 2 3 .

: FEC, FAC. .

6 .

: .

TAXOL, TAXOTERE

.

!

19

1 : ( > 17%) , .

2 & 3 : (< 1.5%)

Espie M, Cuvier C. Drug Saf. 1998;18:135-42. Doll DC et al, Semin Oncol. 1989;16Germann N, Goffinet F, Goldwasser F. Anthracyclines during pregnancy: embryo-fetal outcome in 160 patients. Ann Oncol 2004; 15:146.:337-46.

20

, . 6 : ( ), , . , : 0,04 - 0,2 gray (50 gray ) , . [Fenig et al, Cancer Treat Rev 2001] Gemignani ML, Petrek JA, Borgen PI. Breast cancer and pregnancy. Surg Clin North Am 1999; 79:1157.

21

. Woo, Arch Surg 2003 20% : . , .

22

: Anastrozole, Letrozole, Exemestane .

( ).

23

Trastuzumab (Herceptin) HER2 +++ HER2 Mir, Ann Oncol 2007

: Lapatimib -no datas

24

&

1 : ) (-) . (+) .

) & .

) } Gentillini: Eur.J.Nucl.Mol. Imag. 2010

2 & 3 : ) . ) & +- + .

25

II & V

1 : & .

2 & 3 : `` ``.

; & . : & .Royal College of Obstetrics and Gynaecology, Guideline No 12, revised 2009

26

1 .

.

.

27

.

: 1 .

.

28

& . ., , , . ; . ; - .

29

, (>30 ), . ., 5 . . IV, ., >6 . Ives A et al, BMJ. 2007?334: 194-196

30

.

: .

. .

1 :

31

: , .

.

2 3 : CAF, CEF, TEC.

.

, .

32

!

33